Skip to content

Matching Cognitive Remediation to Cognitive Deficits in Substance-Abusing Inmates

Matching Cognitive Remediation to Cognitive Deficits in Substance-Abusing Inmates

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01428349
Enrollment
180
Registered
2011-09-05
Start date
2011-05-31
Completion date
2013-05-31
Last updated
2015-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Personality Disorders, Psychopathy

Keywords

Incarcerated offenders, emotionally reactive, emotionally stable, psychopathy

Brief summary

This is a 2 -year NIDA funded grant (Co-PIs: Joseph P. Newman, John Curtin, and Carl Lejuez) that examines whether recent progress in characterizing the cognitive deficits associated with psychopathic and externalizing offenders may be used to develop better therapeutic interventions to treat their substance abuse and other self-control problems. Inmates with externalizing or psychopathy will receive one of two computer-based interventions to remediate the core cognitive skills that have been linked to self-regulation deficits in the two groups. One intervention (ACC) targets the affective cognitive control deficits associated with externalizing offenders whereas the other intervention (ATC) targets the attention to context deficits associated with psychopathic offenders. The specific components of the project include: selection and randomization of inmates; pre- and post-treatment behavioral and brain-related (ERP and Startle) measures to evaluate the impact and specificity of the ACC and ATC treatments; and 6 sessions of behavioral (e.g. computerized) and verbal training in ACC or ATC.

Interventions

OTHERCognitive Remediation

Computer training on 3 tasks that targets the attention to context deficits associated with psychopathic offenders. Participants complete 6 training sessions, that include the tasks, feedback and real-world translational examples.

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Male, * ages 18-45 years, * elevated scores of psychopathy or externalizing measures

Exclusion criteria

* currently taking psychotropic medication, * below a 4th grade reading level, * history or current learning disability, * history of head trauma with lasting effects, * current diagnosis of PTSD, * Bipolar, or * psychosis

Design outcomes

Primary

MeasureTime frameDescription
Psychophysiological change from pre-treatment to post-treatment6 weeks after pre-testingWe will measure electrophysiology (EEG), startle responses (EMG measured in microvolts), and behavioral responses on six tasks that measure such processes as affective regulation, distress tolerance, cognitive control, selective attention, and attending to context.

Secondary

MeasureTime frameDescription
Frequency of Conduct Reportswithin 3 months of participationAssess change in the frequency of institution conduct reports post-treatment. We will compare frequency of these reports pre-treatment and post-treatment.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026